Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Liver energy demand from recycling may sustain a costly muscle–liver

In a subset of aging humans, liver energy demand from recycling muscle into could sustain muscle activity after stress. Adequate tests showing no or only would reject the proposed self-maintaining loop in the tested setting.

Omega Point 1.5

Stage of verification

  1. Hypothesis published2026-10-10
  2. Not enough research data
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Biological function

Muscle glycolysis supplies lactate that the liver uses to synthesize glucose, replenishing glucose availability through exchange between muscle and liver. Hepatic glucose synthesis consumes energy; the record treats its greater energetic cost relative to the preceding muscle glycolysis as an unverified background assumption.Lactate-to-glucose recycling

Direction

Lens

Puts the cause in what the system spends, stores and runs short of.Resource and energy

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Goal
Ускорение возрастной уязвимости вследствие взаимного усиления локальных компенсаций
Competing hypotheses
2
Published
2026-10-10
Engine version
Omega Point 1.5
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
5 / 10Silver-bullet potential
Not ratedSupport from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    A process in which produced by muscle is converted into by the liver and returned to muscle

    Where this hypothesis actsMuscle and liver after ordinary activity in a proposed subset of aging humans with excessive recycling

    Hypotheses on this target 1
    Lactate-to-glucose recyclingInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Inhibition

    Reduce excessive

    With whatNot stated in the record

    HowA proposed that preserves availability and necessary compensation; no selective intervention is supplied

    Possible result

    Possible improvement in sustained muscle recovery without increasing

    From the recordReducing excessive recycling while preserving glucose availability and necessary compensation could improve sustained muscle recovery without increasing intrinsic muscle respiratory capacity.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recycling
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Ordinary activity could leave some older people's organs keeping each other busy after the original need has passed. The unexpected move is to propose that the liver's cost of recycling muscle waste helps restart the muscle activity that supplies that waste. This is a hypothesis generated by the pipeline, not a measured result, and neither its proposed nor its ability to sustain itself has been established.

The proposed mechanism, link by link
  1. Muscle sugar breakdown produces that reaches the liver.
  2. The liver returns carbon as , at an assumed energy cost greater than the preceding muscle sugar breakdown supplied.
  3. The liver's increased energy demand sustains a through circulation or .
  4. That renews muscle sugar breakdown and supplies further for liver recycling.
  5. Mutual reinforcement changes ordinary recovery into a self-maintaining costly state after activity ends, although the separated organs would recover under matched conditions.
  6. Reducing excess recycling while preserving supply and necessary responses is predicted to interrupt the cycle and improve sustained muscle recovery.
A picture for it

A recycling service spends so much effort processing a workshop's leftovers that it sends the workshop an order to make more, creating more leftovers for collection. The unusual claim is that the recycler's workload generates the next order after the original job is finished.

Where the picture breaks: Organs do not place orders, and recycling cost does not automatically create a biological signal. The proposed signal, its dependence on liver energy demand and its strength and timing all require identification.

  1. Master questionstep 01 of 04

    Radically slowing human aging is the ultimate goal.

    Rests on: The supplied goal identifies human aging as the outcome to change; it supplies no particular mechanism for changing it.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Local adjustments that help individual parts of the body cope are proposed to reinforce one another and accelerate vulnerability with age.

    Rests on: The goal requires an explanation of what drives aging, but does not itself connect mutually reinforcing adjustments to increasing vulnerability.

    Leap

    The transition needs a basis for attributing accelerating age-related vulnerability to interactions between local compensations. Neither the master question nor the supplied screened sources establishes that connection.

  3. Gap questionstep 03 of 04

    Ordinary stress might be amplified by organs repeatedly affecting one another, or shared triggers and different recovery times might merely make independently recovering organs look mutually dependent.

    Rests on: The preceding stage explicitly identifies mutual reinforcement between local adjustments as the proposed source of increasing vulnerability. Separating genuine interaction from an apparent loop directly examines that claim.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    In some aging humans, muscles could supply excess , a substance formed during sugar breakdown, for the liver to turn back into , a sugar used as fuel. The liver's energy cost is proposed to sustain changes in circulation or , chemical messengers carried through the body, that renew muscle sugar breakdown and supply. Together, the organs would remain in a costly state after ordinary activity ends even though each could recover when their mutual influence is removed under otherwise matched conditions.

    Rests on: The preceding question supplies the distinction between a self-sustaining interaction and independent recovery. The specific muscle–liver explanation adds assumed recycling costs and an unidentified caused by the liver's energy demand.

    Assumption

    The endpoint explicitly assumes excess recycling, the relevant energy accounting, transmission caused by liver energy demand, a primary causal role and self-sustained persistence. Their existence and quantitative importance in the proposed human subgroup remain unverified; being a proposed hypothesis is not itself the support problem.

What is carried, and what is not. Two screened sources discuss the recycling background: the abstract in Pharmacological Reports (2021; S1) links tumor-related recycling to increased production and energy expenditure, while the abstract in Supportive Care in Cancer (1993; S4) reports increased liver production and recycling-related processes in advanced cancer; neither establishes the proposed muscle source, or persistence after ordinary activity in aging humans. No supplied source establishes the sequence end to end, and Brain, Behavior, and Immunity (2020; S2) instead suggests reduced liver formation in a mouse tumor model, without confirming causation or applicability to humans.S1S4S2

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The transition needs a basis for attributing accelerating age-related vulnerability to interactions between local compensations. Neither the master question nor the supplied screened sources establishes that connection. Establish the missing link before relying on this step.
  • Hypothesis. The endpoint explicitly assumes excess recycling, the relevant energy accounting, transmission caused by liver energy demand, a primary causal role and self-sustained persistence. Their existence and quantitative importance in the proposed human subgroup remain unverified; being a proposed hypothesis is not itself the support problem.
How a result here could mislead · 3
  • Less leaving a muscle could be mistaken for less being formed there. Changed , use or storage could produce that result without reducing the muscle activity claimed to sustain the loop. What closes it: The proposed and must distinguish local formation from , use, storage changes and export. Where those quantities cannot be separated, are required rather than a claim that muscle production fell.
  • A muscle response to reduced liver recycling could be credited to lower liver energy demand when it actually follows another liver output or direct exposure to the intervention. Even blocking and replacing a would not, by itself, show that energy demand generated it. What closes it: Liver energy demand must be varied independently while specified competing outputs are matched, with the actual allowed to respond; complementary tests must vary competing outputs while demand is matched. The intervention must be shown to stay restricted to the liver, and restoration of the relevant demand must restore the signal and muscle response. No qualifying manipulation is supplied, so failure to achieve this separation leaves demand dependence unresolved.
  • Long recovery could be called a self-sustaining loop even if both organs are independently recovering at different speeds or remain exposed to a common driver. A simplified muscle–liver preparation could also give a misleading negative result if it omits the proposed circulation or hormone route. What closes it: Complete interacting and separated systems require matched inputs, tissue support and prior local conditions, with the proposed return route represented. Recovery ranges and an observation duration must be fixed before assessing persistence. The supplied prediction is truncated during these requirements, so the complete persistence criterion and any omitted provisions cannot be assessed.

What would make this wrong. The strong chain would fail if adequately resolved measurements found no quantitatively important excess recycling in the proposed subgroup, or if a validated change in the relevant liver energy demand failed to change the and muscle production while competing influences were matched. It would also fail as a claim of self-sustained persistence if complete, adequately observed interacting systems simply recovered at different rates rather than maintaining the costly state. A failed intervention that never changed its intended target, or a preparation missing the return route, would not supply those observations.

What it would change. If the strong claim held, vulnerability after ordinary activity in the identified human subgroup would partly arise from organs sustaining each other's energy demand, even when each organ retains the ability to recover. Work toward slowing aging would then need to distinguish harmful interactions from useful coordination and assess whether reducing the interaction improves recovery and total energy use across the person. That would still not establish radical slowing of human aging, a safe treatment, or exclusion of the supplied kidney–muscle and gut–liver alternatives, which could coexist with this mechanism.

Sources read · 5

8 literature searches, 3 full texts, 2 abstract-only; 5 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1BackgroundAbstract only

Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison. · Pharmacological reports : PR · 2021

“Thus, Cori cycle between organs and cancerous cells contributes to increased glucose production and energy expenditure.”

Does not settle: The abstract concerns tumor-derived lactate in cancer cachexia, not muscle-derived lactate after ordinary activity in aging humans. It does not establish ATP-equivalent accounting, the quantitative contribution of recycling, demand-dependent liver-to-muscle signaling, causal primacy, reciprocal autonomous persistence, delayed recovery, or benefits from reducing recycling.

S2Contradicts it

Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue. · Brain, behavior, and immunity · 2020

“Hepatic metabolic reprogramming could impact activity by inhibiting the Cori cycle, thereby limiting gluconeogenesis and leading to a proximal buildup of lactate ( ).”

Does not settle: The source does not test aging humans, excessive lactate-to-glucose recycling, hepatic ATP demand, a demand-dependent liver-to-muscle return signal, causal primacy, autonomous post-stress persistence, or whether reducing recycling improves recovery. Its small mouse tumor model instead suggests impaired gluconeogenesis and explicitly cannot confirm causation or human generalizability.

S3Background

Plasma Metabolomics Profile of "Insulin Sensitive" Male Hypogonadism after Testosterone Replacement Therapy. · International journal of molecular sciences · 2022

“Thus, lactate accumulation might not imply a state of anaerobic glycolysis but simply a state of accelerated glycolysis (glycolytic flux is higher than the tricarboxylic acid cycle flux) [ ], and/or higher lactate production.”

Does not settle: The source does not establish muscle-to-liver lactate recycling, hepatic gluconeogenic ATP demand, demand-dependent liver-to-muscle signaling, causal primacy, post-stress persistence, aging-specific effects, or whether reducing recycling improves muscle recovery or whole-person energy balance.

S4BackgroundAbstract only

Pathophysiology of cancer cachexia. · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 1993

“Rates of glucose production by the liver, gluconeogenesis and glycolysis to lactate (Cori cycle) are increased, fat mobilisation and oxidation are accelerated.”

Does not settle: The abstract concerns advanced cancer cachexia, not aging humans after ordinary activity. It does not quantify the energetic cost or muscle-to-liver lactate flux, distinguish lactate production from net release and hepatic uptake, show that hepatic demand causes cardiovascular or endocrine return signals, establish reciprocal coupling, causal primacy or autonomous persistence, or test whether reducing recycling improves muscle recovery or whole-person outcomes.

S5Background

Whole-Body Vibration Partially Reverses Aging-Induced Increases in Visceral Adiposity and Hepatic Lipid Storage in Mice. · PloS one · 2016

“One explanation pertinent to these data may be that aging promotes glycolysis to compensate for a diminished mitochondrial capacity to oxidize pyruvate; i . e . the so-called Warburg effect, in aging skeletal muscle [ ]. This is in agreement with elevated lactate levels in tissues of aged mice [ ].”

Does not settle: This source does not establish muscle-to-liver lactate-to-glucose recycling, its energetic cost or quantitative contribution, demand-dependent liver-to-muscle signaling, causal primacy, autonomous post-stress persistence, recovery effects, or benefit from reducing recycling. The reported observations are in aged mice, not the proposed subset of aging humans.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Does human aging prolong stress through organs amplifying each other, or through shared triggers and different recovery speeds?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does human aging amplify ordinary stress through , or do common inputs and unequal recovery delays create an apparent loop while each organ remains independently stable?

What this question is asking

The question concerns why changes in organ function might persist after an everyday stress has ended, and whether aging changes that process. It asks whether organs repeatedly drive further changes in one another, or whether shared triggers, lingering damage, and different recovery speeds explain the same pattern without such reinforcement. The proposed measurements concern , meaning the body's activation of resources to respond, and , meaning blood flow through tissue. The distinguishing comparison is whether these changes fade during recovery or become amplified again because of effects passing between organs, and whether that differs with age. The question presents competing explanations rather than an established claim that aging creates a harmful loop.

What the terms mean
Human aging
Changes in people as they grow older. Here, aging is the proposed influence on the strength or duration of stress responses, but the supplied sources do not establish that influence.
Ordinary stress
An everyday challenge that provokes a bodily response. The supplied input does not specify the challenge, its intensity, or its duration.
Reciprocal organ feedback
A change in one organ affects another, and an effect from the second returns to influence the first. Feedback describes a pattern of causation; observing changes in both organs does not by itself establish it.
Amplification
A disturbance becomes stronger through the effects it produces. In this question, the proposed reinforcement passes between organs and may renew or prolong their responses.
Shared triggers or common inputs
Influences that affect more than one organ. They can produce related changes without those organs causing the changes in one another.
Recovery delays
Differences in how long responses take to fade after a challenge. Different delays can produce a sequence of changes that resembles feedback.
Independent stability
An organ's tendency to return toward its usual state after a disturbance without requiring reinforcement from another organ. It does not mean that the organ has no connections to the rest of the body.
Residual injury or lingering damage
Damage that remains after the original challenge has ended. The question includes it as a possible reason for slow recovery, not as a demonstrated finding in aging humans.
Mobilization
Activation of the body's resources to respond to a challenge. The supplied input does not specify which measurement represents this broad process.
Perfusion
Blood flow through tissue. Its deviation from the usual level is one of the outcomes the gap detail wants explained.
Baseline
A reference state, such as a measurement before stress. Returning toward baseline describes recovery relative to that reference, without specifying how much recovery is sufficient.
Response trajectory
The pattern of a measurement over time. A trajectory can show persistence or recovery without revealing what caused the pattern.
Brain-signal–fluid coupling
A measured relationship between a brain blood-oxygen-related signal and cerebrospinal fluid, the fluid surrounding the brain and spinal cord. S1 reports changes in this relationship; alone does not establish which process causes another.
Association
A measured relationship between changes or observations. An association does not, by itself, show that one causes the other.
Acute pancreatitis
A sudden inflammatory illness of the pancreas, an organ involved in digestion and blood-sugar regulation. S2 addresses lung and intestinal injury in this disease setting.
Inflammatory activators and mediators
Substances that initiate or carry processes involved in inflammation, the body's response to injury or other challenges. These are broad functional classes; S2 describes their participation in mutually reinforcing activity.
Signaling inside cells
Processes through which a cell responds to a signal and changes its activity. In S2's account, these processes connect inflammatory activation to the release of further inflammatory .
Vicious cycle
A reinforcing process in which harmful effects help sustain or increase further harmful effects. S2 uses this description in its disease context; that does not establish the proposed loop in ordinary stress or aging.
Endpoint
An outcome used to assess the question. Here, the intended outcomes include the persistence, decline, or renewed amplification of and tissue blood-flow changes.
What turns on the answer
  • Aging strengthens reciprocal amplification Under this outcome, a stress-related change in one organ would affect another, whose response would feed back and reinforce the first change. Stronger reinforcement with age would help explain renewed or prolonged disturbance after the original trigger ends, so recovery could not be understood solely from each organ's separate recovery speed.
  • Shared triggers and separate recovery explain persistence Under this outcome, several organs would respond to a common influence and then recover at different speeds, potentially with lingering damage slowing some responses. Their staggered changes could resemble a loop even while each organ tends back toward its usual state without reinforcement from another organ. Attributing that pattern to reciprocal amplification would assign causation to the sequence itself.
  • Both mechanisms contribute Under this outcome, shared triggers or lingering damage would sustain some changes while reciprocal effects between organs would reinforce others. The duration of the response alone would not identify how much each mechanism contributes or whether aging changes either contribution.
Why it matters

A shared trigger can affect several organs, and different recovery speeds can make their changes appear in sequence. That sequence alone does not establish that one organ caused the next change or that the effects returned to reinforce the first. If reciprocal reinforcement exists, an organ's continuing disturbance could depend on signals arriving from elsewhere even after the original stress ends. If recovery is independent, treating the sequence as a reinforcing loop would misidentify what sustains the changes. Neither supplied source establishes which explanation applies to human aging.

What is already established

RL-2/3 human and sleep-related muscle evidence reveal delays and persistence, but do not identify .

What would have to be true

and deviations decay within or recovery windows, without renewed amplification after ordinary stress ends.

What is missing

Determine whether causes persistence or whether shared inputs, residual injury, and independent recovery delays explain the same .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

HERETICAL, provisional and conditional: In a subset of aging humans, excessive muscle-to-liver could become a primary generator of post-stress . Muscle supplies ; returns while consuming more than the preceding muscle generated. This energetic accounting is a background assumption unverified by the supplied archive, and its quantitative contribution in the proposed subgroup is unknown. Increased energetic demand is hypothesized to sustain and , which renews and supplies further . The requires energetic demand to cause the . A that changes independently of demand could establish a different liver-to-muscle mechanism but would leave this mechanism unresolved. , formation, , , accumulation and are distinct quantities. The strong claim remains that maintains an unnecessarily costly state after ordinary activity ends despite recovery of the constituent organs under otherwise matched . Excess recycling, demand-dependent transmission, and are unverified assumptions. or would establish a narrower result. Reducing excessive recycling while preserving availability and necessary compensation could improve sustained muscle recovery without increasing . Functional benefit, whole-person energetic benefit and radical slowing of human aging remain separate unestablished outcomes.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

First establish whether a quantitatively important excess-recycling exists after matched mild activity. Combine complementary and , and an . Account for circulating , , alternative , other sources and . For a defined muscle , equals local formation plus minus , other and export; equals export minus . alone cannot identify production. Report where formation, or cannot be separated. Bound using regional or independently validated mechanistic measurements; , alone and an concentration alone cannot identify recycling-specific demand. Define as attributable to the relevant processing over a specified interval, as a candidate demand-transmitting or , and as specified competing , or changes with a possible demand-independent action. These are experimental variables requiring identification, not observed . Identify 's origin, , , and delay. Validate a and exclude direct muscle exposure to it or its . Match concentration and delivery, , oxygen, , and independently imposed ; independently replay altered . Then add a . In one experimental series, independently vary within the relevant while matching the specified and allowing to respond. The predicts a change in followed by a corresponding change in independently resolved . In a complementary series, vary candidate while and are matched. A muscle response fully attributable to without an independently demonstrated -to- effect supports collateral rather than establishing the . If is itself proposed to be , first test whether changing causes its production; subsequent at fixed tests only. Never the actual in a test intended to establish intact transmission. A validated restoration of the relevant demand during continued recycling reduction, at matched competing outputs, should restore and muscle production if demand is the operative cause. Generic consumption in another , , injury or altered concentration does not qualify as equivalent demand restoration. Independent or a quantitatively identified must separate the effects; correlated measurements and alone are insufficient. No qualifying manipulation is supplied. If separation is infeasible, even successful and justify only liver-to-muscle , leaving demand dependence unresolved. In separate , should remove the transmitted muscle response and replacement should restore it despite reduced recycling. Independent replacement should fail to restore the loop only if a non- demand-dependent closes it; include the replacement's production, delivery, and other-organ costs in whole-person accounting. A fall in with unchanged formation does not confirm the mechanism. Compare complete coupled and uncoupled systems with matched , , oxygen, waste removal, tissue support and local history. Before testing persistence, specify individualized recovery ranges, required duration within those ranges, an based on independently measured , and measurements of residual tissue injury and retained states. Estimate independently and predict . The strong claim additionally predicts a post-input state incompatible with measured and alternatives, and termination of that state after specific . Longer recovery or a alone is insufficient; finite observation cannot prove indefinite persistence. Under , processing may fall while muscle production follows residual injury or upstream activation. constrain only the tested subgroup and window when , , and are adequate.

States a measurable outcome; comparing rivals needs more conditions. The chunk specifies an observable sequence under defined comparative conditions and a condition distinguishing collateral signaling from support for the proposed mechanism. No rival prediction is supplied. The chunk states conditional, observable loss and restoration of responses and termination of a post-input state. It explicitly leaves demand dependence unresolved without a qualifying separation manipulation. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

All measurements and interventions are proposed. must be checked for the actual and sampling schedule. can constrain expenditure only with explicit assumptions about production, and other work; describe a stock rather than turnover. characterization requires specified and cannot be replaced by assuming that a reports the relevant . No selective recycling intervention, independent manipulation, collateral-output or complete systemic preparation is supplied. Each would require target-engagement, viability, and . Matching one measured output does not establish that every collateral output is controlled. A can investigate exchange but cannot establish an omitted , or return . An independently validated representation of missing components permits explicitly conditional conclusions only. Broad clinical gluconeogenesis inhibition cannot isolate the mechanism. No safe human treatment regimen is established.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

First establish whether a quantitatively important excess-recycling exists after matched mild activity. Combine complementary and , and an . Account for circulating , , alternative , other sources and . For a defined muscle , equals local formation plus minus , other and export; equals export minus . alone cannot identify production. Report where formation, or cannot be separated. Bound using regional or independently validated mechanistic measurements; , alone and an concentration alone cannot identify recycling-specific demand. Define as attributable to the relevant processing over a specified interval, as a candidate demand-transmitting or , and as specified competing , or changes with a possible demand-independent action. These are experimental variables requiring identification, not observed . Identify 's origin, , , and delay. Validate a and exclude direct muscle exposure to it or its . Match concentration and delivery, , oxygen, , and independently imposed ; independently replay altered . Then add a . In one experimental series, independently vary within the relevant while matching the specified and allowing to respond. The predicts a change in followed by a corresponding change in independently resolved . In a complementary series, vary candidate while and are matched. A muscle response fully attributable to without an independently demonstrated -to- effect supports collateral rather than establishing the . If is itself proposed to be , first test whether changing causes its production; subsequent at fixed tests only. Never the actual in a test intended to establish intact transmission. A validated restoration of the relevant demand during continued recycling reduction, at matched competing outputs, should restore and muscle production if demand is the operative cause. Generic consumption in another , , injury or altered concentration does not qualify as equivalent demand restoration. Independent or a quantitatively identified must separate the effects; correlated measurements and alone are insufficient. No qualifying manipulation is supplied. If separation is infeasible, even successful and justify only liver-to-muscle , leaving demand dependence unresolved. In separate , should remove the transmitted muscle response and replacement should restore it despite reduced recycling. Independent replacement should fail to restore the loop only if a non- demand-dependent closes it; include the replacement's production, delivery, and other-organ costs in whole-person accounting. A fall in with unchanged formation does not confirm the mechanism. Compare complete coupled and uncoupled systems with matched , , oxygen, waste removal, tissue support and local history. Before testing persistence, specify individualized recovery ranges, required duration within those ranges, an based on independently measured , and measurements of residual tissue injury and retained states. Estimate independently and predict . The strong claim additionally predicts a post-input state incompatible with measured and alternatives, and termination of that state after specific . Longer recovery or a alone is insufficient; finite observation cannot prove indefinite persistence. Under , processing may fall while muscle production follows residual injury or upstream activation. constrain only the tested subgroup and window when , , and are adequate.

  • What would separate them

    Potassium-driven acid retention may weaken muscle potassium uptake and amplify kidney stress predicts: Measure dietary entry separately from , regional muscle and release, urinary , , , excretion, acid production, , relevant and . is ammonium plus minus , expressed as equivalent amounts over the same interval. is operationally the in determined by to a specified reference , with conventions reported. requires an ; redistributes or binds rather than automatically eliminating them. does not by itself establish the acid exposure at muscle. Identify the relevant , and reaching muscle using direct measurements where feasible or an independently validated with . If the interval permits negligible or insufficient muscle exposure, the mechanism remains unsupported even with reduced ammonium excretion. Replay the at matched , , , and other relevant inputs, and measure regional , release, and delay. Separately replay the resulting secondary trajectory in at matched acid exposure and other inputs; quantify total . Both independently estimated and must predict the on held-out ordinary challenges. A candidate muscle-specific intervention qualifies only if it selectively removes the acid-associated defect while its independent effects on , and renal exposure are quantified. Test it in a of participant-relevant acid, , hormonal and tissue states, including and . Validate that transfer to the corresponding coupled states; do not subtract a single baseline effect from a without demonstrating that transfer. Under the loop, interruption removes the predicted acid-mediated secondary rise and renewed beyond . Under or shared hormonal dysfunction, acid transmission is absent, too weak or too late, although nonspecific enhancement or can still improve concentrations. If no selective interruption or defensible is available, report the identified local responses and leave unresolved. Separately demonstrate that each protective function alone accommodates the same load over the same horizon and limits, with shared determinants and the other 's support specified, before interpreting joint indicator failure as failed . Follow later release and eventual elimination. Acid exposure developing only after the relevant muscle response rejects the timing claim in the tested setting; a slower interaction remains a separate unestablished possibility. require verified , adequate , relevant exposures and represented .

  • What would separate them

    Gut–liver feedback may prolong cortisol exposure by suppressing its breakdown predicts: First separate , , , , and using specialist , , measurements and over repeated . Establish ; report bounds when these determinants cannot be separated. Specify whether is referenced to free or total concentration. Establish a contribution independently through regional or - measurements. E_H denotes an unidentified candidate , not an identified . Before claiming an -specific defect, identify the or defined reaction sequence, , irreversible fate, contribution and response to participant-range inflammatory exposure. Measure and candidate under matched conditions; a changed alone is insufficient. A validated would need to change as predicted while alternative and are characterized. Until these steps identify E_H, the parent remains a . Next replay participant-measured concentrations, durations and recovery periods in containing and necessary immune cells, distinguishing responses from direct immune . M_G denotes an unidentified liver-active gut output. Determine its cellular source, production rate, molecular identity or explicitly characterized , transport, , and removal, and the resulting . Local gut abundance or cannot substitute for exposure. If direct exposure measurements are unavailable, use a prospectively specified with independently constrained and . Test whether the supported exposure range overlaps the measured . Suppression only at higher concentrations demonstrates , not operation of the human . At fixed and non-gut inflammatory inputs, selective gut interruption should increase -resolved after direct exposure to the intervention and is excluded. using the supported exposure profile should restore suppression. This establishes a only if and delivery are adequate. In a separate , the initial improvement should lower , reduce gut output and yield additional recovery. replacement should remove the ; the initial direct consequence of gut interruption can remain. restoration followed by replacement alone fits a . Estimate both tissue , transport, production and , and with delays. Test whether their independently measured ranges predict a persistent post-stress state and its interruption, versus , on new observations. Include after increased rather than treating it as zero. A persistent state may coexist with without requiring that one local positive exceed every opposing process; the complete dynamics must determine the outcome. If compensation restores exposure, predict reduced or absent exposure-mediated functional benefit rather than inferring benefit from alone. Fixed apparatus tests exposure-response behavior only. constrain adequately represented, specifically perturbed within the tested range. Sleep, activity, and the response to a subsequent safe stress require separate assessment.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

describes without restored , and describes between and . These contextual summaries motivate expenditure-side questions but provide no admissible archived evidence for excessive recycling, demand-dependent or .

Subfield revised

The account of fatigue, and would require revision if ordinarily restorative liver-muscle recycling were shown to generate persistent demand before intrinsic muscle energy failure through a quantitatively sufficient, independently demonstrated -demand return .

Testable surprise

Reducing recycling could improve sustained post-stress muscle recovery despite reducing an ordinarily useful -replenishment , with availability maintained and unchanged. The specific mechanism predicts reduced through a demand-dependent . should restore production, but its success establishes demand dependence only when the upstream -to- link has been independently separated from collateral changes.

Why this is not the mainstream account

Not established. , and stress-driven are comparison frameworks. The empty archive establishes neither their detailed application nor the priority or novelty of this precise claim. The HERETICAL creative role remains provisional.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.